Collagen Matrix
Dan Ammon Inaugurated Into The National Academy of Engineering (NAE)
We are excited to honor and celebrate our Vice President of R&D Dan Ammon and his recent inauguration into the National Academy of Engineering (NAE). Dan brings more than 30 years of experience in biomedical device research and development to Collagen Matrix, Inc. Election to the NAE is among the highest professional distinctions accorded to an…
Read MoreCollagen Matrix Names Charles (Chip) Ross as Vice President, Human Resources
We are pleased to announce the appointment of Charles (Chip) Ross as Vice President of Human Resources at Collagen Matrix, Inc. Mr. Ross joined Collagen Matrix in December 2022. Chip brings 30+ years of human resources leadership experience across multiple industries and organizations, with focus in talent development, organizational effectiveness and culture planning. Prior to…
Read MoreCollagen Matrix Names Tim Starr Chief Operating Officer
Collagen Matrix Names Tony Orsini Chief Operating Officer We are pleased to announce the appointment of Tim Starr as Chief Operating Officer at Collagen Matrix, Inc. Tim is a Biochemist with more than 30 years of leadership experience in life sciences manufacturing and supply chain. Most recently he was Vice President of Operations for Boston…
Read MoreCollagen Matrix Acquires Polyganics
The Investment Expands CMI’s Regenerative Medicine Portfolio, R&D Capabilities and International Manufacturing Operations Oakland, N.J., October 5, 2022 – Collagen Matrix, Inc. (“Collagen Matrix”), a global leader in regenerative medicine and a Linden Capital Partners (“Linden”) portfolio company, today announced the acquisition of Polyganics, B.V (“Polyganics”). Polyganics is a medical technology company that develops and…
Read MoreCollagen Matrix, Inc. Announces 510(k) Clearance for Fibrillar Collagen Wound Dressing, Expanding Offerings for Advanced Wound Market
Collagen Matrix, Inc. Announces 510(k) Clearance for Fibrillar Collagen Wound Dressing, Expanding Offerings for Advanced Wound Market OAKLAND, NJ — 6/28/22 — Collagen Matrix, Inc., a leader in regenerative medicine, global manufacturer of collagen and other biomaterial-based medical devices, and Linden Capital Partners portfolio company (“Collagen Matrix” or “the Company”), announced today its 510(k) Clearance…
Read MoreCollagen Matrix Names Timothy J. Scannell to its Board of Directors
Collagen Matrix Names Timothy J. Scannell to its Board of Directors Collagen Matrix Inc., a leader in regenerative medicine, global manufacturer of collagen and mineral-based medical devices, and Linden Capital Partners portfolio company, announced today the appointment of Timothy J. Scannell to its board of directors. A seasoned and dynamic medical device leader, Mr. Scannell…
Read MoreCollagen Matrix Acquires Sunstar’s GUIDOR® Synthetic Bone Graft & Membrane Business
Collagen Matrix Acquires Sunstar’s GUIDOR® Synthetic Bone Graft & Membrane Business Collagen Matrix, Inc., a global leader in regenerative, collagen-based, xenograft-derived medical devices, and portfolio company of Linden Capital Partners (“Linden”), announced today the acquisition of Sunstar’s Degradable Solutions division (the “Company”), including its GUIDOR® branded line of resorbable synthetic medical implants. Founded in 1999, Degradable…
Read MoreCollagen Matrix, Inc. Receives FDA 510(k) Clearance of a Bioactive Moldable Bone Graft Matrix
Collagen Matrix, Inc. Receives FDA 510(k) Clearance of a Bioactive Moldable Bone Graft Matrix Collagen Matrix, Inc., a leader in regenerative medicine and a global manufacturer of collagen and mineral based medical devices announced today the FDA 510(k) clearance of its innovative line of Mineral Collagen Composite Bioactive Moldable Bone Graft Matrix through its Spine…
Read MoreCollagen Matrix Launches OssiMend® Spine and DuraMatrix® Dural Repair Products in Asia
Collagen Matrix, Inc., a leader in regenerative medicine and a global manufacturer of collagen and mineral based medical devices announced today its first entrance into the India market with two product lines, OssiMend® bone graft matrices from its Spine Business Unit and DuraMatrix®membranes from its Dural Repair Business Unit. Collagen Matrix Launches OssiMend® Spine and…
Read MoreCollagen Matrix Celebrates 20 Years of Science, Technology and Innovation
Collagen Matrix Celebrates 20 Years of Science, Technology and Innovation It started with an idea that transformed into a success story, 20 years in the making. Today, Collagen Matrix, celebrating its 20th anniversary, has developed collagen and mineral based medical devices that have helped patients worldwide with over 7.5 million products sold. The Company has…
Read More